In a recent review article, in which it was suggested that MPO release is a consequence of the cytokine storm that is induced by SARS-CoV-2 infection, Goud et al addressed a potential role for elevated MPO levels in driving the clinical deterioration that precedes the onset of severe COVID-19 (142). The gene discussed is MPO; the disease is COVID-19.